E-LIB Suche - Ergebnisse für: Gullbo, Joachim

1

Pharmacokinetics and Metabolism of Melflufen, an Alkylating..:

Huledal, Gunilla ; Ruiz‐Garcia, Ana ; Kawakatsu, Sonoko...
The Journal of Clinical Pharmacology. 64 (2023) 2 - p. 240-252 , 2023

Link: https://doi.org/10.1002/..

2

Melphalan flufenamide inhibits osteoclastogenesis by suppre..:

Byrgazov, Konstantin ; Lind, Thomas ; Rasmusson, Annica J....
Bone Reports. 15 (2021) - p. 101098 , 2021

Link: https://doi.org/10.1016/..

3

Melflufen: A Peptide–Drug Conjugate for the Treatment of Mu..:

Mateos, María-Victoria ; Bladé, Joan ; Bringhen, Sara...
Journal of Clinical Medicine. 9 (2020) 10 - p. 3120 , 2020

Link: https://doi.org/10.3390/..

4

Targeting aggressive osteosarcoma with a peptidase-enhanced..:

Byrgazov, Konstantin ; Anderson, Claes ; Salzer, Benjamin...
Therapeutic Advances in Medical Oncology. 12 (2020) - p. 175883592093789 , 2020

Link: https://doi.org/10.1177/..

5

Phase 1 study of the protein deubiquitinase inhibitor VLX15..:

Rowinsky, Eric K. ; Paner, Agne ; Berdeja, Jesus G....
Investigational New Drugs. 38 (2020) 5 - p. 1448-1453 , 2020

Link: https://doi.org/10.1007/..

6

Melflufen for relapsed and refractory multiple myeloma:

Oriol, Albert ; Larocca, Alessandra ; Leleu, Xavier...
Expert Opinion on Investigational Drugs. 29 (2020) 10 - p. 1069-1078 , 2020

Link: https://doi.org/10.1080/..

7

A novel tumor spheroid model identifies selective enhanceme..:

Karlsson, Henning ; Senkowski, Wojciech ; Fryknäs, Mårten...
Oncotarget. 10 (2019) 51 - p. 5372-5382 , 2019

Link: https://doi.org/10.18632..

8

Analysis of determinants for in vitro resistance to the sma..:

Mofers, Arjan ; Perego, Paola ; Selvaraju, Karthik...
PLOS ONE. 14 (2019) 10 - p. e0223807 , 2019

Link: https://doi.org/10.1371/..

9

Towards repositioning of quinacrine for treatment of acute ..:

Eriksson, Anna ; Chantzi, Efthymia ; Fryknäs, Mårten...
Leukemia Research. 63 (2017) - p. 41-46 , 2017

Link: https://doi.org/10.1016/..

10

Mechanistic characterization of a copper containing thiosem..:

Karlsson, Henning ; Fryknäs, Mårten ; Strese, Sara...
Oncotarget. 8 (2017) 18 - p. 30217-30234 , 2017

Link: https://doi.org/10.18632..

11

Synergistic effects of combining proteasome inhibitors with..:

Sooman, Linda ; Gullbo, Joachim ; Bergqvist, Michael...
BMC Research Notes. 10 (2017) 1 - p. , 2017

Link: https://doi.org/10.1186/..

12

Melflufen - a peptidase-potentiated alkylating agent in cli..:

Wickström, Malin ; Nygren, Peter ; Larsson, Rolf...
Oncotarget. 8 (2017) 39 - p. 66641-66655 , 2017

Link: https://doi.org/10.18632..

13

Preclinical activity of melflufen (J1) in ovarian cancer:

Carlier, Charlotte ; Strese, Sara ; Viktorsson, Kristina...
Oncotarget. 7 (2016) 37 - p. 59322-59335 , 2016

Link: https://doi.org/10.18632..

14

Expression of possible targets for new proteasome inhibitor..:

Delforoush, Maryam ; Berglund, Mattias ; Edqvist, Per‐Henrik...
European Journal of Haematology. 98 (2016) 1 - p. 52-56 , 2016

Link: https://doi.org/10.1111/..

15

A novel alkylating agent Melflufen induces irreversible DNA..:

Ray, Arghya ; Ravillah, Durgadevi ; Das, Deepika S....
British Journal of Haematology. 174 (2016) 3 - p. 397-409 , 2016

Link: https://doi.org/10.1111/..